“Speaking truth to power”
- a Quaker maxim.
 
Top News arrow News / Infomails
News and Infomails from AHRP
Marketing Trumps Safety: the case of Antipsychotics Print E-mail
Thursday, 04 June 2009
"The story's pretty clear, and pretty embarrassing for the profession of psychiatry, which has allowed itself to be led by marketing," says Dr. Robert Rosenheck, Yale.
Read more...
 
USA Today: Conflicts of interest bedevil psychiatric drug research Print E-mail
Thursday, 04 June 2009
Psychiatry's leadership is scrambling and fumbling in its effort to explain why it's collusion with industry for pay is okay.
Read more...
 
Antidepressants-Paxil, Prozac, Zoloft Increase Risk of Breast Cancer Print E-mail
Sunday, 31 May 2009

Inexplicably, the FDA has dragged its feet about adding a warning label to both tamoxefin and the antidepressants, Paxil, Prozac and Zoloft--despitethe unanimous recommendation of its own advisory panel in 2006.

Read more...
 
Army Doctor Accused of Research Fraud Takes Leave From University Print E-mail
Sunday, 24 May 2009
Given the serious charges against Dr. Kuklo--including fraud, forgery, and conducting an unapproved experiment on soldiers--the University of Washington's failure to take action until a series of articles in The New York Times and pressure brought to bear by Sen. Charles Grassley, speaks volumes about a pervasive culture of arrogance in academia.
Read more...
 
More...
<< Start < Prev 11 12 13 14 15 16 17 18 19 20 Next > End >>

Results 211 - 224 of 753
[ Back ]
(C) 2012 Alliance for Human Research Protection
CMS installation and website development by Anne Krauss

General Terms & Disclaimer:

This site is not a monologue of truth. It is a catalyst for public debate about medical research conduct. The reader is urged to confront officials to clarify issues mentioned herein. This site is designed strictly to provide information for critical, literary, academic an public usage. A qualified and trustworthy medical professional must be consulted regarding medical issues, treatments, diagnoses, etc.

Please read the General Terms and Conditions of this agreement entirely and carefully before accessing this web site. By accessing the site, you agree to be bound by the terms and conditions listed herein. [continue]